🇺🇸 FDA
Patent

US 10041053

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

granted A61PA61P31/00A61P31/04

Quick answer

US patent 10041053 (Rationally-designed single-chain meganucleases with non-palindromic recognition sequences) held by Precision BioSciences, Inc. expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P31/00, A61P31/04, A61P31/12, A61P33/02